Leukaemia

Results: 157



#Item
1Why we focus on Leukaemia Leukaemias can be acute or chronic and arise from the myeloid or lymphoid lineage. The treatment of chronic myeloid leukamia (CML) has been revolutionised by the use of agents such as Imatinib t

Why we focus on Leukaemia Leukaemias can be acute or chronic and arise from the myeloid or lymphoid lineage. The treatment of chronic myeloid leukamia (CML) has been revolutionised by the use of agents such as Imatinib t

Add to Reading List

Source URL: www.bci.qmul.ac.uk

- Date: 2016-04-04 11:36:10
    2Why we focus on Haematologic Malignancies Leukaemia and lymphoma represent the most common cancers that occur in younger patients, with lymphoma their most common cause of cancer death, and, therefore, these malignancies

    Why we focus on Haematologic Malignancies Leukaemia and lymphoma represent the most common cancers that occur in younger patients, with lymphoma their most common cause of cancer death, and, therefore, these malignancies

    Add to Reading List

    Source URL: www.bci.qmul.ac.uk

    Language: English - Date: 2016-04-04 11:36:10
    3Medical Hypotheses, 864–871  http://intl.elsevierhealth.com/journals/mehy Could visible light contribute to the development of leukaemia and other cancers in

    Medical Hypotheses, 864–871 http://intl.elsevierhealth.com/journals/mehy Could visible light contribute to the development of leukaemia and other cancers in

    Add to Reading List

    Source URL: www.um.es

    Language: English - Date: 2006-06-30 19:35:46
      4correspondence  Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up Despite their efficacy in inducing deep and

      correspondence Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up Despite their efficacy in inducing deep and

      Add to Reading List

      Source URL: michorlab.dfci.harvard.edu

      Language: English - Date: 2013-12-12 17:40:33
      5LETTER  doi:nature09999 A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia

      LETTER doi:nature09999 A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia

      Add to Reading List

      Source URL: michorlab.dfci.harvard.edu

      Language: English - Date: 2014-08-06 11:15:16
      6PRESS RELEASE N° June 2015 Even low doses of radiation increase risk of dying from leukaemia in nuclear workers, says IARC

      PRESS RELEASE N° June 2015 Even low doses of radiation increase risk of dying from leukaemia in nuclear workers, says IARC

      Add to Reading List

      Source URL: www.iarc.fr

      Language: English - Date: 2015-06-22 03:09:51
        7dercum and imatinib, imatinib chronic myeloid leukaemia, antacids and imatinib. imatinib imatinib mesylate and thalate. imatinib cat imatinib lipase, imatinib and p-gp ddi imatinib and etanercept dasatinib and imatinib

        dercum and imatinib, imatinib chronic myeloid leukaemia, antacids and imatinib. imatinib imatinib mesylate and thalate. imatinib cat imatinib lipase, imatinib and p-gp ddi imatinib and etanercept dasatinib and imatinib

        Add to Reading List

        Source URL: rivervest.com

        Language: English - Date: 2015-07-20 08:22:26
        8A Response to the Magnox Sites RSA Consultation  Annex 1: Radiation and Health Case control study of leukaemia among young people near La Hague nuclear reprocessing plant: the environmental hypothesis revisited.

        A Response to the Magnox Sites RSA Consultation Annex 1: Radiation and Health Case control study of leukaemia among young people near La Hague nuclear reprocessing plant: the environmental hypothesis revisited.

        Add to Reading List

        Source URL: www.fraw.org.uk

        - Date: 2015-04-07 17:21:33
          9A Response to the Magnox Sites RSA Consultation  Annex 1: Radiation and Health Death rates from leukaemia are higher than expected in areas around nuclear sites in Berkshire and Oxfordshire. Chris Busby/Molly Scott Cato.

          A Response to the Magnox Sites RSA Consultation Annex 1: Radiation and Health Death rates from leukaemia are higher than expected in areas around nuclear sites in Berkshire and Oxfordshire. Chris Busby/Molly Scott Cato.

          Add to Reading List

          Source URL: www.fraw.org.uk

          - Date: 2015-04-07 17:21:43
            10We trust them cos we have added Cardiac Risk In The Young, Ehlers-Danloss UK, Against Breast Cancer, Breast Cancer Care, Leukaemia Research and Multiple Sclerosis digoxin 0.2 mg capsule UK to our editors for review. Less

            We trust them cos we have added Cardiac Risk In The Young, Ehlers-Danloss UK, Against Breast Cancer, Breast Cancer Care, Leukaemia Research and Multiple Sclerosis digoxin 0.2 mg capsule UK to our editors for review. Less

            Add to Reading List

            Source URL: thesermonsdomain.com

            - Date: 2015-07-05 12:15:48